Don’t miss the latest developments in business and finance.

Home / Companies / News / Ranbaxy to earmark 20% more for R&D

Ranbaxy to earmark 20% more for R&D

Image
Joe C Mathew New Delhi
Last Updated : Jan 26 2013 | 1:24 AM IST
Connect with us
Facebook IconLinkedIN Icon
  
Connect with us on WhatsApp

Also Read

Novartis to proceed with case against Indian patent law

Patent row: Ranbaxy takes on IPA

Mashelkar panel`s view on wider patentability flayed

Patent tieup draws flak from NGOs

It`s business, honey

First Published: Jan 28 2007 | 12:00 AM IST

Explore News

Next Story